新型降脂药PCSK9抑制剂依洛尤单抗的研究进展(7)
[20] HIRAYAMA A，HONARPOUR N，YOSHIDA M，et al. Effects of evolocumab (AMG 145)，a monoclonal antibody to PCSK9，in hypercholesterolemic，statin-treated Japanese patients at high cardiovascular risk：primary results from the phase 2 YUKAWA study[J]. Circ J，2014，78 (5)：1073-1082.[21] BLOM DJ ......
您现在查看是摘要页，全文长 2602 字符。